Australian Pharmaceutical Industries Ltd
ASX:API
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Australian Pharmaceutical Industries Ltd
ASX:API
|
AU |
|
Websolute SpA
MIL:WEB
|
IT |
|
B
|
Blucora Inc
F:3EV
|
US |
|
P
|
Polynet PCL
SET:POLY
|
TH |
|
A
|
Advanced Information Technology Public Company Limited
SET:AIT
|
TH |
|
B
|
BGrimm Power PCL
SET:BGRIM
|
TH |
|
Central Retail Corporation PCL
SET:CRC
|
TH |
|
Victory Capital Holdings Inc
NASDAQ:VCTR
|
US |
|
Dal'nevostochnaya Energeticheskaya Kompaniya PAO
MOEX:DVEC
|
RU |
|
O
|
Orlen SA
PSE:PKN
|
PL |
|
A
|
AMA Marine PCL
SET:AMA
|
TH |
|
C
|
Circor International Inc
F:CCI
|
US |
|
C
|
Cigna Group
XMUN:CGN
|
US |
|
P
|
Plan B Media PCL
SET:PLANB
|
TH |
Dividends
Dividend Yield
Australian Pharmaceutical Industries Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Australian Pharmaceutical Industries Ltd
API have
decreased
by 0%.
Payout Ratio
Australian Pharmaceutical Industries Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for API is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
API Price
Australian Pharmaceutical Industries Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -19% |
| Market Capitalization | 753.8m AUD |
| Shares Outstanding | 492 656 000 |
| Percentage of Shares Shorted |
N/A
|
API Return Decomposition
Main factors of price return
Stock Splits
API's latest stock split occurred on Oct 21, 2009
The company executed a 788-for-667 stock split, meaning that for every 667 shares held, investors received 788 new shares.
Before the split, API traded at 0.893 per share. Afterward, the share price was about 0.4757.
The adjusted shares began trading on Oct 21, 2009. This was the only stock split in API's history.
